APO Research
Talk to an analyst

APO RESEARCH · REPORT

IL-12 Receptor Antagonist

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global IL-12 Receptor Antagonist Industry Growth and Trends Forecast to 2032

27 December 2025100 pages

Choose your research edition.

Industry ResearchIL-12 Receptor Antagonist Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-12 Receptor Antagonist Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal IL-12 Receptor Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-12 Receptor Antagonist Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-12 Receptor Antagonist Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global IL-12 Receptor Antagonist market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for IL-12 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for IL-12 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-12 Receptor Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-12 Receptor Antagonist include Amgen, Biocon Biologics, Celltrion, Janssen Pharmaceuticals, Samsung Bioepis, Sandoz, Teva, Bio-Thera Solutions and Huadong Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global IL-12 Receptor Antagonist market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The IL-12 Receptor Antagonist market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global IL-12 Receptor Antagonist market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to IL-12 Receptor Antagonist.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global IL-12 Receptor Antagonist market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

IL-12 Receptor Antagonist Market by Company

Amgen

Biocon Biologics

Celltrion

Janssen Pharmaceuticals

Samsung Bioepis

Sandoz

Teva

Bio-Thera Solutions

Huadong Medicine

Qyuns Therapeutics

IL-12 Receptor Antagonist Segment by Type

Ustekinumab

Briakinumab

Other

IL-12 Receptor Antagonist Segment by Application

Plaque Psoriasis

Crohn's Disease

Ulcerative Colitis

Rheumatoid Arthritis

Other

IL-12 Receptor Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-12 Receptor Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-12 Receptor Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-12 Receptor Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-12 Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of IL-12 Receptor Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ustekinumab Table 2. Major Company of Briakinumab Table 3. Major Company of Other Table 4. Global IL-12 Receptor Antagonist Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 6. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Type (2021-2026) Table 7. Global IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 8. Global IL-12 Receptor Antagonist Sales Market Share in Value by Type (2021-2026) Table 9. Global IL-12 Receptor Antagonist Price by Type (2021-2026) & (US$/Unit) Table 10. Global IL-12 Receptor Antagonist Sales by Type (2027-2032) & (K Units) Table 11. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Type (2027-2032) Table 12. Global IL-12 Receptor Antagonist Sales by Type (2027-2032) & (US$ Million) Table 13. Global IL-12 Receptor Antagonist Sales Market Share in Value by Type (2027-2032) Table 14. Global IL-12 Receptor Antagonist Price by Type (2027-2032) & (US$/Unit) Table 15. North America IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 16. North America IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 17. Europe IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 18. Europe IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 22. Latin America IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa IL-12 Receptor Antagonist Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa IL-12 Receptor Antagonist Sales by Type (2021-2026) & (US$ Million) Table 25. IL-12 Receptor Antagonist Industry Trends Table 26. IL-12 Receptor Antagonist Industry Drivers Table 27. IL-12 Receptor Antagonist Industry Opportunities and Challenges Table 28. IL-12 Receptor Antagonist Industry Restraints Table 29. Global IL-12 Receptor Antagonist Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global IL-12 Receptor Antagonist Revenue Market Share by Company (2021-2026) Table 31. Global IL-12 Receptor Antagonist Sales by Company (2021-2026) & (K Units) Table 32. Global IL-12 Receptor Antagonist Sales Share by Company (2021-2026) Table 33. Global IL-12 Receptor Antagonist Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global IL-12 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global IL-12 Receptor Antagonist Major Company Production Sites and Headquarters Table 36. Global IL-12 Receptor Antagonist Company, Product Type & Application Table 37. Global IL-12 Receptor Antagonist Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global IL-12 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global IL-12 Receptor Antagonist Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global IL-12 Receptor Antagonist Sales by Region (2021-2026) & (K Units) Table 42. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Region (2021-2026) Table 43. Global IL-12 Receptor Antagonist Sales by Region (2021-2026) & (US$ Million) Table 44. Global IL-12 Receptor Antagonist Sales Market Share in Value by Region (2021-2026) Table 45. Global IL-12 Receptor Antagonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global IL-12 Receptor Antagonist Sales by Region (2027-2032) & (K Units) Table 47. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Region (2027-2032) Table 48. Global IL-12 Receptor Antagonist Sales by Region (2027-2032) & (US$ Million) Table 49. Global IL-12 Receptor Antagonist Sales Market Share in Value by Region (2027-2032) Table 50. Global IL-12 Receptor Antagonist Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global IL-12 Receptor Antagonist Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 53. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Application (2021-2026) Table 54. Global IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 55. Global IL-12 Receptor Antagonist Sales Market Share in Value by Application (2021-2026) Table 56. Global IL-12 Receptor Antagonist Price by Application (2021-2026) & (US$/Unit) Table 57. Global IL-12 Receptor Antagonist Sales by Application (2027-2032) & (K Units) Table 58. Global IL-12 Receptor Antagonist Sales Market Share in Volume by Application (2027-2032) Table 59. Global IL-12 Receptor Antagonist Sales by Application (2027-2032) & (US$ Million) Table 60. Global IL-12 Receptor Antagonist Sales Market Share in Value by Application (2027-2032) Table 61. Global IL-12 Receptor Antagonist Price by Application (2027-2032) & (US$/Unit) Table 62. North America IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 63. North America IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 64. Europe IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 65. Europe IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 69. Latin America IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa IL-12 Receptor Antagonist Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa IL-12 Receptor Antagonist Sales by Application (2021-2026) & (US$ Million) Table 72. Amgen Company Information Table 73. Amgen Business Overview Table 74. Amgen IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Amgen IL-12 Receptor Antagonist Product Portfolio Table 76. Amgen Recent Development Table 77. Biocon Biologics Company Information Table 78. Biocon Biologics Business Overview Table 79. Biocon Biologics IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Biocon Biologics IL-12 Receptor Antagonist Product Portfolio Table 81. Biocon Biologics Recent Development Table 82. Celltrion Company Information Table 83. Celltrion Business Overview Table 84. Celltrion IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Celltrion IL-12 Receptor Antagonist Product Portfolio Table 86. Celltrion Recent Development Table 87. Janssen Pharmaceuticals Company Information Table 88. Janssen Pharmaceuticals Business Overview Table 89. Janssen Pharmaceuticals IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Janssen Pharmaceuticals IL-12 Receptor Antagonist Product Portfolio Table 91. Janssen Pharmaceuticals Recent Development Table 92. Samsung Bioepis Company Information Table 93. Samsung Bioepis Business Overview Table 94. Samsung Bioepis IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Samsung Bioepis IL-12 Receptor Antagonist Product Portfolio Table 96. Samsung Bioepis Recent Development Table 97. Sandoz Company Information Table 98. Sandoz Business Overview Table 99. Sandoz IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sandoz IL-12 Receptor Antagonist Product Portfolio Table 101. Sandoz Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva IL-12 Receptor Antagonist Product Portfolio Table 106. Teva Recent Development Table 107. Bio-Thera Solutions Company Information Table 108. Bio-Thera Solutions Business Overview Table 109. Bio-Thera Solutions IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Bio-Thera Solutions IL-12 Receptor Antagonist Product Portfolio Table 111. Bio-Thera Solutions Recent Development Table 112. Huadong Medicine Company Information Table 113. Huadong Medicine Business Overview Table 114. Huadong Medicine IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Huadong Medicine IL-12 Receptor Antagonist Product Portfolio Table 116. Huadong Medicine Recent Development Table 117. Qyuns Therapeutics Company Information Table 118. Qyuns Therapeutics Business Overview Table 119. Qyuns Therapeutics IL-12 Receptor Antagonist Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Qyuns Therapeutics IL-12 Receptor Antagonist Product Portfolio Table 121. Qyuns Therapeutics Recent Development Table 122. North America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 124. North America IL-12 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 125. North America IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America IL-12 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 127. North America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America IL-12 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 129. North America IL-12 Receptor Antagonist Market Share by Country (2021-2026) Table 130. North America IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America IL-12 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 132. Europe IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 134. Europe IL-12 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 135. Europe IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe IL-12 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 137. Europe IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe IL-12 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe IL-12 Receptor Antagonist Market Share by Country (2021-2026) Table 140. Europe IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe IL-12 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific IL-12 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific IL-12 Receptor Antagonist Market Share by Country (2021-2026) Table 150. Asia-Pacific IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific IL-12 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 152. Latin America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 154. Latin America IL-12 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 155. Latin America IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America IL-12 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America IL-12 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America IL-12 Receptor Antagonist Market Share by Country (2021-2026) Table 160. Latin America IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America IL-12 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa IL-12 Receptor Antagonist Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa IL-12 Receptor Antagonist Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa IL-12 Receptor Antagonist Market Share by Country (2021-2026) Table 170. Middle East and Africa IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa IL-12 Receptor Antagonist Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. IL-12 Receptor Antagonist Distributors List Table 175. IL-12 Receptor Antagonist Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. IL-12 Receptor Antagonist Image Figure 2. Global IL-12 Receptor Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-12 Receptor Antagonist Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-12 Receptor Antagonist Sales (2021-2032) & (K Units) Figure 5. Ustekinumab Image Figure 6. Global Ustekinumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Briakinumab Image Figure 8. Global Briakinumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global IL-12 Receptor Antagonist Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global IL-12 Receptor Antagonist Market Share by Type 2025 VS 2032 Figure 13. North America IL-12 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 14. North America IL-12 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 15. Europe IL-12 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 16. Europe IL-12 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 19. Latin America IL-12 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 20. Latin America IL-12 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 IL-12 Receptor Antagonist Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Plaque Psoriasis Image Figure 26. Global Plaque Psoriasis Sales YoY Growth (2021-2032) & (K Units) Figure 27. Crohn's Disease Image Figure 28. Global Crohn's Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Ulcerative Colitis Image Figure 30. Global Ulcerative Colitis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Rheumatoid Arthritis Image Figure 32. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global IL-12 Receptor Antagonist Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global IL-12 Receptor Antagonist Market Share by Application 2025 VS 2032 Figure 37. North America IL-12 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 38. North America IL-12 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 39. Europe IL-12 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 40. Europe IL-12 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific IL-12 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 43. Latin America IL-12 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 44. Latin America IL-12 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa IL-12 Receptor Antagonist Sales Market Share in Value by Application in 2025 Figure 47. North America IL-12 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America IL-12 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America IL-12 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America IL-12 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe IL-12 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe IL-12 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe IL-12 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe IL-12 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific IL-12 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific IL-12 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific IL-12 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific IL-12 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America IL-12 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America IL-12 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America IL-12 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America IL-12 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa IL-12 Receptor Antagonist Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa IL-12 Receptor Antagonist Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa IL-12 Receptor Antagonist Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa IL-12 Receptor Antagonist Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. IL-12 Receptor Antagonist Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. IL-12 Receptor Antagonist Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Ustekinumab
  • Briakinumab
  • Other
Applications
  • Plaque Psoriasis
  • Crohn's Disease
  • Ulcerative Colitis
  • Rheumatoid Arthritis
  • Other
Companies covered
  • Amgen
  • Biocon Biologics
  • Celltrion
  • Janssen Pharmaceuticals
  • Samsung Bioepis
  • Sandoz
  • Teva
  • Bio-Thera Solutions
  • Huadong Medicine
  • Qyuns Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IL-12 Receptor Antagonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global IL-12 Receptor Antagonist Sales Estimates and Forecasts (2021-2032)
  5. 1.3 IL-12 Receptor Antagonist Market by Type
  6. 1.3.1 Ustekinumab
  7. 1.3.2 Briakinumab
  8. 1.3.3 Other
  9. 1.4 Global IL-12 Receptor Antagonist Market Size by Type
  10. 1.4.1 Global IL-12 Receptor Antagonist Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global IL-12 Receptor Antagonist Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global IL-12 Receptor Antagonist Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America IL-12 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe IL-12 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific IL-12 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America IL-12 Receptor Antagonist Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa IL-12 Receptor Antagonist Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 IL-12 Receptor Antagonist Industry Trends
  2. 2.2 IL-12 Receptor Antagonist Industry Drivers
  3. 2.3 IL-12 Receptor Antagonist Industry Opportunities and Challenges
  4. 2.4 IL-12 Receptor Antagonist Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by IL-12 Receptor Antagonist Revenue (2021-2026)
  2. 3.2 Global Top Players by IL-12 Receptor Antagonist Sales (2021-2026)
  3. 3.3 Global Top Players by IL-12 Receptor Antagonist Price (2021-2026)
  4. 3.4 Global IL-12 Receptor Antagonist Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-12 Receptor Antagonist Major Company Production Sites & Headquarters
  6. 3.6 Global IL-12 Receptor Antagonist Company, Product Type & Application
  7. 3.7 Global IL-12 Receptor Antagonist Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-12 Receptor Antagonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-12 Receptor Antagonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-12 Receptor Antagonist Tier 1, Tier 2, and Tier 3
4 IL-12 Receptor Antagonist Regional Status and Outlook
  1. 4.1 Global IL-12 Receptor Antagonist Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global IL-12 Receptor Antagonist Historic Market Size by Region
  3. 4.2.1 Global IL-12 Receptor Antagonist Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global IL-12 Receptor Antagonist Sales in Value by Region (2021-2026)
  5. 4.2.3 Global IL-12 Receptor Antagonist Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global IL-12 Receptor Antagonist Forecasted Market Size by Region
  7. 4.3.1 Global IL-12 Receptor Antagonist Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global IL-12 Receptor Antagonist Sales in Value by Region (2027-2032)
  9. 4.3.3 Global IL-12 Receptor Antagonist Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 IL-12 Receptor Antagonist by Application
  1. 5.1 IL-12 Receptor Antagonist Market by Application
  2. 5.1.1 Plaque Psoriasis
  3. 5.1.2 Crohn's Disease
  4. 5.1.3 Ulcerative Colitis
  5. 5.1.4 Rheumatoid Arthritis
  6. 5.1.5 Other
  7. 5.2 Global IL-12 Receptor Antagonist Market Size by Application
  8. 5.2.1 Global IL-12 Receptor Antagonist Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global IL-12 Receptor Antagonist Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global IL-12 Receptor Antagonist Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America IL-12 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe IL-12 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific IL-12 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America IL-12 Receptor Antagonist Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa IL-12 Receptor Antagonist Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen
  2. 6.1.1 Amgen Company Information
  3. 6.1.2 Amgen Business Overview
  4. 6.1.3 Amgen IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen IL-12 Receptor Antagonist Product Portfolio
  6. 6.1.5 Amgen Recent Developments
  7. 6.2 Biocon Biologics
  8. 6.2.1 Biocon Biologics Company Information
  9. 6.2.2 Biocon Biologics Business Overview
  10. 6.2.3 Biocon Biologics IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Biocon Biologics IL-12 Receptor Antagonist Product Portfolio
  12. 6.2.5 Biocon Biologics Recent Developments
  13. 6.3 Celltrion
  14. 6.3.1 Celltrion Company Information
  15. 6.3.2 Celltrion Business Overview
  16. 6.3.3 Celltrion IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Celltrion IL-12 Receptor Antagonist Product Portfolio
  18. 6.3.5 Celltrion Recent Developments
  19. 6.4 Janssen Pharmaceuticals
  20. 6.4.1 Janssen Pharmaceuticals Company Information
  21. 6.4.2 Janssen Pharmaceuticals Business Overview
  22. 6.4.3 Janssen Pharmaceuticals IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Janssen Pharmaceuticals IL-12 Receptor Antagonist Product Portfolio
  24. 6.4.5 Janssen Pharmaceuticals Recent Developments
  25. 6.5 Samsung Bioepis
  26. 6.5.1 Samsung Bioepis Company Information
  27. 6.5.2 Samsung Bioepis Business Overview
  28. 6.5.3 Samsung Bioepis IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Samsung Bioepis IL-12 Receptor Antagonist Product Portfolio
  30. 6.5.5 Samsung Bioepis Recent Developments
  31. 6.6 Sandoz
  32. 6.6.1 Sandoz Company Information
  33. 6.6.2 Sandoz Business Overview
  34. 6.6.3 Sandoz IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sandoz IL-12 Receptor Antagonist Product Portfolio
  36. 6.6.5 Sandoz Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva IL-12 Receptor Antagonist Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Bio-Thera Solutions
  44. 6.8.1 Bio-Thera Solutions Company Information
  45. 6.8.2 Bio-Thera Solutions Business Overview
  46. 6.8.3 Bio-Thera Solutions IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bio-Thera Solutions IL-12 Receptor Antagonist Product Portfolio
  48. 6.8.5 Bio-Thera Solutions Recent Developments
  49. 6.9 Huadong Medicine
  50. 6.9.1 Huadong Medicine Company Information
  51. 6.9.2 Huadong Medicine Business Overview
  52. 6.9.3 Huadong Medicine IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Huadong Medicine IL-12 Receptor Antagonist Product Portfolio
  54. 6.9.5 Huadong Medicine Recent Developments
  55. 6.10 Qyuns Therapeutics
  56. 6.10.1 Qyuns Therapeutics Company Information
  57. 6.10.2 Qyuns Therapeutics Business Overview
  58. 6.10.3 Qyuns Therapeutics IL-12 Receptor Antagonist Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Qyuns Therapeutics IL-12 Receptor Antagonist Product Portfolio
  60. 6.10.5 Qyuns Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America IL-12 Receptor Antagonist Sales by Country
  2. 7.1.1 North America IL-12 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America IL-12 Receptor Antagonist Sales by Country (2021-2026)
  4. 7.1.3 North America IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 7.2 North America IL-12 Receptor Antagonist Market Size by Country
  6. 7.2.1 North America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America IL-12 Receptor Antagonist Market Size by Country (2021-2026)
  8. 7.2.3 North America IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe IL-12 Receptor Antagonist Sales by Country
  2. 8.1.1 Europe IL-12 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe IL-12 Receptor Antagonist Sales by Country (2021-2026)
  4. 8.1.3 Europe IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 8.2 Europe IL-12 Receptor Antagonist Market Size by Country
  6. 8.2.1 Europe IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe IL-12 Receptor Antagonist Market Size by Country (2021-2026)
  8. 8.2.3 Europe IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific IL-12 Receptor Antagonist Sales by Country
  2. 9.1.1 Asia-Pacific IL-12 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific IL-12 Receptor Antagonist Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific IL-12 Receptor Antagonist Market Size by Country
  6. 9.2.1 Asia-Pacific IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific IL-12 Receptor Antagonist Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America IL-12 Receptor Antagonist Sales by Country
  2. 10.1.1 South America IL-12 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America IL-12 Receptor Antagonist Sales by Country (2021-2026)
  4. 10.1.3 South America IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 10.2 South America IL-12 Receptor Antagonist Market Size by Country
  6. 10.2.1 South America IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America IL-12 Receptor Antagonist Market Size by Country (2021-2026)
  8. 10.2.3 South America IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa IL-12 Receptor Antagonist Sales by Country
  2. 11.1.1 Middle East and Africa IL-12 Receptor Antagonist Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa IL-12 Receptor Antagonist Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa IL-12 Receptor Antagonist Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa IL-12 Receptor Antagonist Market Size by Country
  6. 11.2.1 Middle East and Africa IL-12 Receptor Antagonist Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa IL-12 Receptor Antagonist Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa IL-12 Receptor Antagonist Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 IL-12 Receptor Antagonist Value Chain Analysis
  2. 12.1.1 IL-12 Receptor Antagonist Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 IL-12 Receptor Antagonist Production Mode & Process
  7. 12.2 IL-12 Receptor Antagonist Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 IL-12 Receptor Antagonist Distributors
  10. 12.2.3 IL-12 Receptor Antagonist Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst